Cumulative experience with Solcoderm in the treatment of basal cell epithelioma.
Over 300 patients with basal cell epithelioma have been treated with Solcoderm during the past 4 years. The treatment is simple and effective for small superficial lesions and particularly useful in patients with periocular or multiple lesions.
D000085:Acetates / Q000627:therapeutic use; D019342:Acetic Acid; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002280:Basal Cell Carcinoma / Q000188:drug therapy*; D003300:Copper / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005142:Eyelid Neoplasms / Q000188:drug therapy*; D006801:Humans; D007773:Lactates / Q000627:therapeutic use; D009566:Nitrates / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy*
D000085:Acetates; D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D004338:Drug Combinations; D007773:Lactates; D009566:Nitrates; D003300:Copper; D019342:Acetic Acid